Peter J Connolly

Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors.

Xin Chen, Yan Zhang, S. Emanuel, 2005, Journal of medicinal chemistry.

The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.

S. Emanuel, C. Rugg, R. H. Gruninger, 2005, Cancer research.

Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

Mary Adams, Niranjan Pandey, Terry V Hughes, 2008, Molecular Pharmacology.

4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors.

Mary Adams, Niranjan Pandey, Robert H Gruninger, 2008, Bioorganic & medicinal chemistry letters.

Molecular dynamics of the long neurotoxin LSIII.

Jeffrey C Hoch, Alan S Stern, A. Stern, 2003, Biochemistry.

Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases.

Mary Adams, Niranjan Pandey, Terry V Hughes, 2008, Bioorganic & medicinal chemistry letters.

Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitors.

S. Emanuel, P. Connolly, Shenlin Huang, 2006, Bioorganic & medicinal chemistry letters.

SAR maps: a new SAR visualization technique for medicinal chemists.

Dimitris K Agrafiotis, Victor S Lobanov, Michael Farnum, 2007, Journal of medicinal chemistry.